Department of Radiation Oncology

Analysis of antioxidant Factors in Patients' Blood with chronic Degenerative and inflammatory Diseases in the Course of Low-Dose Radiotherapy (2020) Hehlgans S, Donaubauer AJ, Becker I, Frey B, Oppermann J, Ott O, Weissmann T, et al. Conference contribution Development of an immunological prognostic Signature in metastatic Patients who were treated with Immune Checkpoint Inhibitors as part of the ST-ICI Study (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, et al. Conference contribution Effects of Radon-Spa-Therapy on Patients with musculoskeletal Diseases (2020) Becker I, Donaubauer AJ, Klein G, Fournier C, Fietkau R, Frey B, Gaipl U Conference contribution Influence of ex vivo Hyperthermia caused by Warm Water or Microwave Irradiation in a Circulatory System and/or Irradiation on the immunogenic Potential of B16 Melanoma and MCF-7 / MDA-MB-231 Breast Cancer Cells (2020) Hader M, Savcigil DP, Rosin A, Gekle S, Wadepohl M, Fietkau R, Frey B, Gaipl U Conference contribution Accelerated Partial Breast Irradiation: Identification of High Risk Tumors in Early Hormone Receptor-positive Breast Cancer by Macrophage Shift Classification (2020) Schnellhardt S, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, Beckmann M, et al. Conference contribution Interstitial PDR-brachytherapy alone or in combination with EBRT for malignancies of the vulvar area: the UK Erlangen experience (2020) Knippen S, Kreppner S, Lotter M, Fietkau R, Strnad V Conference contribution Local and systemic immunological Effects of intraoperative Radiotherapy (IORT) for Breast Cancer (2020) Tiefenthaller A, Brix N, Hennel R, Pazos M, Kost B, Rack B, Von Bodungen , et al. Conference contribution Influence of the ALK Kinase Inhibitors Crizotinib and Alectinib on healthy and malignant Lung Cell Lines in a Combination Therapy with ionizing Radiation (2020) Schultz AK, Jost T, Hecht M, Fietkau R, Distel L Conference contribution Oncological Patients with systemic Lupus Erythematosus have a clear risk of increased Radiation Sensitivity (2020) Schenker H, Schuster B, Hecht M, Fietkau R, Distel L Conference contribution High locoregional Control Rates after Radio (chemo) Therapy in anaplastic Thyroid Carcinoma - a monocentric Analysis (2020) Schmied M, Semrau S, Hecht M, Lettmaier S, Mantsopoulos K, Traxdorf M, Iro H, et al. Conference contribution